Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wolff

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
Seminars in Oncology|March 1, 1985
High-dose etoposide (VP-16) in small-cell lung cancerF A Greco, D H Johnson, K R Hande, et al.
Leukemia|November 1, 1992
High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant GroupS N Wolff, R A Brown, J W Fay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years laterHillard M Lazarus, Gordon L Phillips, Roger H Herzig, et al.
Cancer Treatment Reports|August 1, 1986
Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosisJ D Hainsworth, S N Wolff, R S Stein, et al.
Cancer Treatment Reports|June 1, 1986
Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimenM R Baer, R S Stein, J P Greer, et al.
Seminars in Oncology|September 1, 1986
High-dose pilot studies in extensive-stage small-cell lung cancerD H Johnson, K R Hande, L L Porter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapyM L McMaster, J P Greer, F A Greco, et al.
Cancer Research|January 1, 1984
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patientsK R Hande, P J Wedlund, R M Noone, et al.
Scientific Reports|April 3, 2024
Real-time monitoring of CdTe quantum dots growth in aqueous solutionP F G M da Costa, L G Merízio, N Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancerD H Johnson, M J DeLeo, K R Hande, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Seminars in Oncology|March 1, 1985
High-dose etoposide (VP-16) in small-cell lung cancerF A Greco, D H Johnson, K R Hande, et al.
Leukemia|November 1, 1992
High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant GroupS N Wolff, R A Brown, J W Fay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years laterHillard M Lazarus, Gordon L Phillips, Roger H Herzig, et al.
Cancer Treatment Reports|August 1, 1986
Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosisJ D Hainsworth, S N Wolff, R S Stein, et al.
Cancer Treatment Reports|June 1, 1986
Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimenM R Baer, R S Stein, J P Greer, et al.
Seminars in Oncology|September 1, 1986
High-dose pilot studies in extensive-stage small-cell lung cancerD H Johnson, K R Hande, L L Porter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapyM L McMaster, J P Greer, F A Greco, et al.
Cancer Research|January 1, 1984
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patientsK R Hande, P J Wedlund, R M Noone, et al.
Scientific Reports|April 3, 2024
Real-time monitoring of CdTe quantum dots growth in aqueous solutionP F G M da Costa, L G Merízio, N Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancerD H Johnson, M J DeLeo, K R Hande, et al.
Pageof 18